Last update 08 May 2025

APP x α-synuclein x CD64 x PRNP

Basic Info

Related Targets
APPα-synucleinCD64[+1]

Related

1
Drugs associated with APP x α-synuclein x CD64 x PRNP
NPT-088
Target
APP x CD64 x PRNP x α-synuclein
Mechanism
APP inhibitors [+4]
Active Org.
Proclara Biosciences, Inc.Proclara Biosciences, Inc.
Originator Org.
Proclara Biosciences, Inc.Proclara Biosciences, Inc.
Active Indication
Parkinsonian Disorders
Inactive Indication
Alzheimer Disease
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with APP x α-synuclein x CD64 x PRNP
NCT03008161
/ CompletedPhase 1
A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Dose Escalation Study of NPT088 in Patients With Probable Alzheimer's Disease
100 Clinical Results associated with APP x α-synuclein x CD64 x PRNP
Login to view more data
100 Translational Medicine associated with APP x α-synuclein x CD64 x PRNP
Login to view more data
0 Patents (Medical) associated with APP x α-synuclein x CD64 x PRNP
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free